Lubiprostone
- Product NDC
- 42291-475
- 11-digit product format
- 422910475
- Labeler code
- 42291
- Product ID
- 42291-475_f1763c5a-5f35-fac0-e053-2995a90a038a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lubiprostone
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA209450
- Marketing category
- ANDA
- Marketing start
- 2023-01-04
- Marketing end
- 0000-00-00
- Substance
- LUBIPROSTONE
- Active strength
- 8 ug/1
- Pharmacologic classes
- Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-475-60 | Lubiprostone | 60 in 1 BOTTLE | CAPSULE | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-475 | LUBIPROSTONE CAPSULE [AVKARE] | 2 | Legacy NDC, 1 package rows | 20230325_f1763c5a-5f36-fac0-e053-2995a90a038a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-475-60 | 42291047560 | 60 CAPSULE in 1 BOTTLE (42291-475-60) | 60 capsule | 2023-01-04 | 0000-00-00 | No | No | Current |